BiotechTube
Home/Memgen/Mark Cantwell, PhD
MC

Mark Cantwell, PhD

Chief Scientific Officer, Director

Memgen

Therapeutic Areas

Oncology

Memgen Pipeline

DrugIndicationPhase
MEM-288Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 1

Leadership Team at Memgen

GB
Gregory Brown, MD, MBA
Chief Executive Officer, Director
RC
Robert Coates, PhD
Chief Operating Officer, Chairman of the Board
View full Memgen profile